Sitemap

EU Expects First COVID Vaccine Application In Coming Days

More...

America’s Biggest Owner Of Farmland Is Now Bill Gates

Bill Gates, the fourth richest person in...

Chairperson-In-Office Ann Linde Presents Sweden’s 2021 Priorities To Permanent Council

Over the coming year, the Swedish Chairpersonship...

Tokyo’s Covid Outbreak Adds To Doubts Over Hosting Olympic Games

A dramatic rise in coronavirus cases in...

Environmental Protection – EU-Serbia Cooperation

The year behind us was certainly challenging...

News

Chairperson-In-Office Ann Linde Presents Sweden’s 2021 Priorities To Permanent Council

Over the coming year, the Swedish Chairpersonship will do its part to ensure that the OSCE can make a...

Tokyo’s Covid Outbreak Adds To Doubts Over Hosting Olympic Games

A dramatic rise in coronavirus cases in Tokyo has reignited speculation about the Olympic Games, which are due to open...

Environmental Protection – EU-Serbia Cooperation

The year behind us was certainly challenging in terms of health protection. Healthy environment was an essential aspect of...

EU Commission Concludes Exploratory Talks With Valneva To Secure A New Potential Vaccine

European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against...

Preconditions For Beginning Of Mass Vaccination Provided

Prime Minister Ana Brnabic pointed out today that there will be enough vaccines available for all citizens who want...

The European Medicines Agency did not name the company it expects to file the application. However, EU leaders hope a vaccine will be available before the end of the year.

The first application for marketing approval of a COVID-19 vaccine in the European Union should arrive in the next few days, according to the European Medicines Agency (EMA).

The drug watchdog did not identify the drugmaker expected to file, however partners Pfizer and BioNTEch are the most advanced in the regulatory approval process. A total of three drugmakers have published late-stage trial data for their respective coronavirus vaccine candidates, including US firm Moderna, and a British partnership between AstraZeneca and Oxford University.

The Pfizer-BioNTech collaboration has already applied for approval in the US, and the UK has asked its medical regulator to assess the vaccine.

Researchers on the US-German vaccine should enjoy a speedy approval process, as they have been allowed to submit data in real-time to the EMA, without waiting for studies to conclude.

The EMA earlier acknowledged it was trying “to speed up” the evaluation process, but said it was “ensuring the same high regulatory standards for quality, safety and efficacy” as for any other drug.

EMA told the AFP news agency that it could approve the first COVID-19 vaccines by the end of the year. Many European countries, including France, Spain and Italy, have based their immunization plans on that basis.

German Chancellor Angela Merkel told lawmakers Thursday that a vaccine may become available before the end of the year.

In the US, if the Food and Drug Administration (FDA) approves accelarated rollout, vaccination efforts may start as early as mid-December.

Related

US Pharma Firm Moderna Says Its COVID-19 Vaccine Is 94.5% Effective

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker...

Oxford Covid Vaccine Works In All Ages, Trials Suggest

Covid vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups One of the world’s leading Covid-19 experimental vaccines produces an...

Vaccination rollout

In China, medical authorities have already begun immunizing high-risk patients. In Russia, two vaccines have been validated for use before the final phase of clinical trials had started.

The candidates that have passed trials all claim more than 90% effiacy, but their results have not yet been backed up by by publication in peer-reviewed journals, which can usually take months.

Price and logistics will also factor in the success of the vaccines. AstraZeneca’s double dose is the cheapest, costing about €2.5 ($3) per dose and requires just a normal fridge temperature. Moderna’s vaccine must be kept at -20 degrees Celsius (-4 Farenheit), while Pfizer’s must be kept at -70C (-94 Farenheit).

Source:  Deutsche Welle

Related Articles

Chairperson-In-Office Ann Linde Presents Sweden’s 2021 Priorities To Permanent Council

Over the coming year, the Swedish Chairpersonship will do its part to ensure that the OSCE can make a real difference on the ground...

Tokyo’s Covid Outbreak Adds To Doubts Over Hosting Olympic Games

A dramatic rise in coronavirus cases in Tokyo has reignited speculation about the Olympic Games, which are due to open in the city in just...

Environmental Protection – EU-Serbia Cooperation

The year behind us was certainly challenging in terms of health protection. Healthy environment was an essential aspect of these efforts, and in 2020,...

EU Commission Concludes Exploratory Talks With Valneva To Secure A New Potential Vaccine

European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with...

Preconditions For Beginning Of Mass Vaccination Provided

Prime Minister Ana Brnabic pointed out today that there will be enough vaccines available for all citizens who want to be vaccinated against coronavirus. During...

Strong Support In Favour Of EU Accession Among Serbian Citizens

Better economic standards, higher salaries and pensions, future job opportunities, visa-free travelling benefits are some of the first associations with the EU according to the latest...

Sweden Takes Over OSCE Chair

Sweden takes over the OSCE Chair today, and will in the coming year focus on defending the European security order, addressing protracted conflicts and...

European Union Heads Sign Brexit Trade Deal

With a call for both sides to look forward to a new chapter in their relationship, top EU officials signed the Brexit trade deal...